{"gene":"NDUFS2","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":2001,"finding":"Missense mutations in NDUFS2 that substitute conserved amino acids cause mitochondrial complex I deficiency, establishing NDUFS2 as a structural/functional subunit of complex I encoded by nuclear DNA.","method":"RT-PCR and direct DNA sequencing of patient cDNA; biochemical complex I deficiency confirmed","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 2 — multiple patient mutations with biochemical complex I deficiency, replicated across multiple families","pmids":["11220739"],"is_preprint":false},{"year":2013,"finding":"NDUFAF7 (a complex I assembly factor) symmetrically dimethylates the ω-NG,NG' atoms of Arg-85 in the NDUFS2 subunit of complex I; this methylation occurs early in assembly and stabilizes a ~400-kDa subcomplex forming the initial nucleus of the peripheral arm.","method":"Mass spectrometry identification of methylated Arg-85; biochemical methyltransferase assay; subcomplex isolation and characterization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical identification of modification site with MS and functional assembly characterization","pmids":["24089531"],"is_preprint":false},{"year":2011,"finding":"The Asp446Asn mutation in NDUFS2 causes a catalytic defect in complex I without reducing complex I abundance, and 3D modeling places Asp446 near the coenzyme Q binding pocket, suggesting the mutation impairs coenzyme Q reduction or coupling to proton pumping; wild-type NDUFS2 transduction rescued the enzymatic defect in patient fibroblasts.","method":"Biochemical complex I activity assay in patient fibroblasts; coenzyme Q analog KM measurements; 3D structural modeling; lentiviral rescue with wild-type NDUFS2","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1–2 — enzymatic assay, structural modeling, and functional rescue by complementation","pmids":["22036843"],"is_preprint":false},{"year":2019,"finding":"NDUFS2 is the molecular oxygen sensor at the rotenone-binding site of complex I in pulmonary artery smooth muscle cells (PASMCs); acute hypoxia reduces NDUFS2 cysteine residues and inhibits complex I, decreasing mitochondrial H2O2, which then increases intracellular Ca2+ to drive hypoxic pulmonary vasoconstriction (HPV). siRNA knockdown of NDUFS2 (but not NDUFS1, the Rieske Fe-S center, or COX4i2) abolished hypoxia-induced Ca2+ increases and attenuated HPV in vivo.","method":"siRNA knockdown in PASMCs; intracellular Ca2+ imaging; H2O2 measurement; NADH/NAD+ ratio; Kv1.5 expression; isolated lung bioassay; in vivo siNdufs2 with rotenone/phenylephrine challenge; redox state of cysteine residues measured during hypoxia","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Ca2+ imaging, H2O2 measurement, in vivo pharmacology, genetic KD with epistasis controls), replicated with different readouts","pmids":["30922174"],"is_preprint":false},{"year":2019,"finding":"S100A4 regulates NDUFS2 expression; depletion of either S100A4 or NDUFS2 inhibits mitochondrial complex I activity, reduces ATP levels, and decreases invasive/metastatic capacity of lung cancer cells, with metabolic shift to glycolysis via hexokinase upregulation.","method":"siRNA silencing of S100A4 and NDUFS2; oxygen consumption rate measurement; ATP assays; 3D invasion assays; in vivo xenograft metastasis models; hexokinase expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple phenotypic readouts in vitro and in vivo, but regulatory mechanism upstream of NDUFS2 not fully resolved","pmids":["30885944"],"is_preprint":false},{"year":2021,"finding":"CRISPR/Cas9 knockout of NDUFS2 in HEK293 cells demonstrates it is required for complex I-specific respiration, ATP production, and cell membrane integrity; loss increases ROS and apoptosis/necrosis. Idebenone treatment partially restored growth, ATP, and oxygen consumption in NDUFS2 mutant cells.","method":"CRISPR/Cas9 knockout; Seahorse respirometry; ROS measurement; ATP assay; cell viability assays; idebenone pharmacological rescue","journal":"Mitochondrion","confidence":"High","confidence_rationale":"Tier 1–2 — clean genetic KO with multiple orthogonal functional readouts plus pharmacological rescue","pmids":["33744462"],"is_preprint":false},{"year":2024,"finding":"The lncRNA DCRT binds PTBP1 in the nucleus of cardiomyocytes to prevent skipping of the third exon of NDUFS2; loss of DCRT causes PTBP1-mediated exon 3 skipping of NDUFS2, producing a truncated isoform that competitively inhibits full-length NDUFS2/complex I activity and binds PRDX5 to suppress its antioxidant activity, leading to mitochondrial dysfunction and dilated cardiomyopathy.","method":"CRISPR-Cas9 DCRT knockout mice; RNA immunoprecipitation; chromatin co-IP; isoform sequencing; Western blot; co-IP of truncated NDUFS2 with PRDX5; complex I activity assay; transverse aortic constriction model; AAV overexpression rescue","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (RIP, co-IP, isoform sequencing, KO mice, in vivo rescue) establishing molecular mechanism","pmids":["38841852"],"is_preprint":false},{"year":2024,"finding":"OTUB1, a deubiquitinase, interacts with NDUFS2 and removes K48-linked polyubiquitin chains from NDUFS2, increasing its protein stability and thereby promoting pancreatic cancer cell survival, proliferation, and migration.","method":"Protein mass spectrometry; co-immunoprecipitation; OTUB1 overexpression/knockdown with NDUFS2 protein level measurement; ubiquitination assay; in vivo xenograft experiments","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP and functional epistasis, but deubiquitination mechanism needs deeper biochemical validation","pmids":["38653740"],"is_preprint":false},{"year":2023,"finding":"PTPMT1 interacts with NDUFS2 (and SLC25A6) in pancreatic cancer cells, and PTPMT1 silencing impairs mitochondrial function, suggesting PTPMT1 regulates mitochondrial activity via this axis.","method":"Co-immunoprecipitation; siRNA knockdown; mitochondrial function assays; PTPMT1 inhibitor (alexidine dihydrochloride)","journal":"American journal of cancer research","confidence":"Low","confidence_rationale":"Tier 3 — single co-IP without deeper mechanistic follow-up of the NDUFS2 interaction","pmids":["37034225"],"is_preprint":false},{"year":2020,"finding":"LASS2 interacts with NDUFS2 (identified by co-IP and LC-MS); this interaction is associated with mtROS production and AMPK phosphorylation, linking the LASS2-NDUFS2 axis to regulation of hepatic lipid metabolism.","method":"Co-immunoprecipitation and LC-MS; LASS2 overexpression/knockdown in hepatocytes; mtROS measurement; AMPK phosphorylation assay","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 — single co-IP/MS with limited mechanistic follow-up of the NDUFS2 interaction specifically","pmids":["32279995"],"is_preprint":false},{"year":2022,"finding":"Disease-causing mutations in NDUFS2 (mapped to subunit interfaces in the E. coli homolog nuoCD) disrupt complex I assembly as demonstrated in a bacterial model system; compound heterozygous mutations were ranked for severity by NADH oxidase activity and co-immunoprecipitation-based assembly assays.","method":"Site-directed mutagenesis of E. coli nuoCD (NDUFS2 ortholog); membrane vesicle NADH oxidase activity assays; co-immunoprecipitation assembly assays; time-delayed expression experiments","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 1–2 — reconstituted bacterial model with mutagenesis and assembly assays, but indirect (bacterial ortholog) system","pmids":["36462614"],"is_preprint":false},{"year":2016,"finding":"Compound heterozygous NDUFS2 mutations (p.Tyr53Cys; p.Tyr308Cys) cause non-syndromic LHON-like optic neuropathy; functional analysis in yeast (Y. lipolytica) showed the severe mutation abolishes complex I while the hypomorphic mutation moderately reduces NADH-ubiquinone oxidoreductase activity, establishing a genotype-phenotype correlation.","method":"Genetic mapping and whole-exome sequencing; functional analysis in patient fibroblasts (complex I abundance and respiratory chain activity); Y. lipolytica ortholog (NUCM) mutagenesis with complex I activity assay","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 — ortholog functional assay in yeast combined with patient fibroblast biochemistry","pmids":["28031252"],"is_preprint":false},{"year":2025,"finding":"ndufs2-/- zebrafish (CRISPR/Cas9-generated) show 80% reduced complex I enzyme activity, severe neuromuscular dysfunction, metabolic disruption (elevated lactate, TCA intermediates, acyl-carnitines), and dysregulation of one-carbon metabolism; folic acid treatment rescued growth defects and hepatomegaly, implicating one-carbon metabolism in CI disease pathophysiology.","method":"CRISPR/Cas9 knockout zebrafish; complex I enzyme activity assay; transcriptome profiling; unbiased metabolomics; folic acid rescue experiment","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic KO with enzymatic confirmation, metabolomics, and pharmacological rescue; preprint","pmids":["40791373"],"is_preprint":true},{"year":2025,"finding":"NDUFS2 acts as a mitochondrial oxygen sensor in human ductus arteriosus smooth muscle cells (DASMC): siNDUFS2 uniquely suppressed O2-induced increases in intracellular Ca2+, cell shortening, and mitochondrial ROS generation, while knockdown of other ETC subunits (NDUFS1, NDUFS7, UQCRFS1, COX4I2) had no effect, and this did not require inhibition of overall mitochondrial respiration.","method":"siRNA knockdown of NDUFS2 and comparator ETC subunits; intracellular Ca2+ imaging; cell length measurements; mitochondrial ROS measurement; micropolarimetry; complex I/III/IV activity assays; 3' RNA sequencing","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal readouts with genetic epistasis controls; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.07.08.663799"],"is_preprint":true}],"current_model":"NDUFS2 is a core catalytic subunit of mitochondrial respiratory chain complex I located at the interface between the peripheral and membrane arms near the coenzyme Q/ubiquinone binding pocket; it harbors iron-sulfur clusters, undergoes symmetric arginine dimethylation at Arg-85 by NDUFAF7 early in complex I assembly, is subject to deubiquitination-mediated stabilization by OTUB1, and its cysteine residues act as redox-sensitive oxygen sensors that couple mitochondrial H2O2 production to intracellular Ca2+ signaling in pulmonary and ductus arteriosus smooth muscle cells, while alternative splicing of its exon 3 (regulated by lncRNA DCRT via PTBP1) produces a dominant-negative isoform that inhibits complex I activity and suppresses PRDX5 antioxidant function."},"narrative":{"teleology":[{"year":2001,"claim":"Identification of patient missense mutations established NDUFS2 as a nuclear-encoded structural/functional subunit whose integrity is required for complex I enzymatic activity.","evidence":"RT-PCR, DNA sequencing, and biochemical complex I assay in patient fibroblasts from multiple families","pmids":["11220739"],"confidence":"High","gaps":["Precise catalytic role of NDUFS2 within complex I was not defined","No structural localization of the mutated residues within the complex"]},{"year":2011,"claim":"Demonstration that the Asp446Asn mutation impairs catalysis without reducing complex I abundance, combined with structural modeling placing Asp446 near the ubiquinone-binding pocket, positioned NDUFS2 as a catalytic subunit at the electron-transfer/proton-pumping interface.","evidence":"Complex I activity and CoQ-analog KM measurements in patient fibroblasts; 3D modeling; lentiviral wild-type NDUFS2 rescue","pmids":["22036843"],"confidence":"High","gaps":["Direct structural evidence for the ubiquinone-binding pocket architecture was lacking in the mammalian complex","Mechanism by which Asp446 participates in catalysis not resolved at atomic level"]},{"year":2013,"claim":"Discovery that NDUFAF7 symmetrically dimethylates Arg-85 of NDUFS2 during early assembly revealed a post-translational modification step that nucleates peripheral arm biogenesis.","evidence":"Mass spectrometry identification of dimethyl-Arg-85; in vitro methyltransferase assay; subcomplex isolation","pmids":["24089531"],"confidence":"High","gaps":["Functional consequence of blocking Arg-85 methylation on assembled complex I activity was not determined","Whether other complex I subunits are co-dependently modified at this stage is unknown"]},{"year":2016,"claim":"Functional analysis of compound heterozygous NDUFS2 mutations in a yeast ortholog system demonstrated allele-specific severity and established a genotype–phenotype correlation with non-syndromic optic neuropathy, expanding the clinical spectrum beyond encephalopathy.","evidence":"Whole-exome sequencing; patient fibroblast biochemistry; Yarrowia lipolytica NUCM mutagenesis with complex I activity assays","pmids":["28031252"],"confidence":"Medium","gaps":["Yeast ortholog system may not fully recapitulate mammalian assembly or tissue-specific phenotypes","Why optic nerve is selectively vulnerable to these particular mutations remains unexplained"]},{"year":2019,"claim":"NDUFS2 was identified as the molecular oxygen sensor in pulmonary artery smooth muscle cells, with its cysteine residues undergoing redox changes during hypoxia that decrease mitochondrial H₂O₂ and trigger Ca²⁺-dependent vasoconstriction — a function not shared by other ETC subunits tested.","evidence":"siRNA knockdown of NDUFS2 and control subunits in PASMCs; intracellular Ca²⁺ imaging; H₂O₂ and NADH/NAD⁺ measurements; cysteine redox profiling; isolated lung bioassay; in vivo siNdufs2 challenge","pmids":["30922174"],"confidence":"High","gaps":["Identity of the specific cysteine residues responsible for oxygen sensing was not determined","Whether this oxygen-sensing mechanism operates in vascular beds beyond pulmonary vasculature was untested"]},{"year":2021,"claim":"CRISPR knockout of NDUFS2 in human cells confirmed it is indispensable for complex I-linked respiration and cell viability, and showed that the CoQ analog idebenone can partially bypass the defect.","evidence":"CRISPR/Cas9 KO in HEK293; Seahorse respirometry; ROS, ATP, and viability assays; idebenone rescue","pmids":["33744462"],"confidence":"High","gaps":["Idebenone rescue was partial — the electron entry point bypassing complex I was not resolved","No in vivo validation of idebenone benefit for NDUFS2 deficiency"]},{"year":2022,"claim":"Modeling disease-causing NDUFS2 mutations in the bacterial ortholog nuoCD showed that mutations at subunit interfaces disrupt complex I assembly, providing a structural rationale for genotype–severity correlations.","evidence":"Site-directed mutagenesis of E. coli nuoCD; membrane vesicle NADH oxidase assays; co-IP assembly assays","pmids":["36462614"],"confidence":"Medium","gaps":["Bacterial system lacks accessory subunits and assembly factors present in mammalian complex I","Assembly kinetics were inferred from endpoint assays, not real-time tracking"]},{"year":2024,"claim":"The lncRNA DCRT was shown to prevent PTBP1-mediated exon 3 skipping of NDUFS2 in cardiomyocytes; loss of DCRT produces a truncated dominant-negative NDUFS2 isoform that inhibits complex I and sequesters PRDX5, causing dilated cardiomyopathy.","evidence":"CRISPR DCRT-KO mice; RNA immunoprecipitation; isoform sequencing; co-IP of truncated NDUFS2 with PRDX5; complex I assays; AAV rescue","pmids":["38841852"],"confidence":"High","gaps":["Whether exon 3-skipped NDUFS2 isoform exists at physiologically relevant levels in human heart disease is unknown","Stoichiometry and structural basis of truncated NDUFS2–PRDX5 interaction not resolved"]},{"year":2024,"claim":"OTUB1 was identified as a deubiquitinase that stabilizes NDUFS2 by removing K48-linked polyubiquitin chains, linking ubiquitin-dependent protein quality control to complex I abundance in cancer cells.","evidence":"Co-IP and mass spectrometry; OTUB1 overexpression/knockdown with NDUFS2 protein measurement; ubiquitination assay; xenograft models","pmids":["38653740"],"confidence":"Medium","gaps":["The E3 ubiquitin ligase that ubiquitinates NDUFS2 is unknown","Whether OTUB1-NDUFS2 regulation occurs in non-cancer physiological contexts is untested","Deubiquitination site(s) on NDUFS2 were not mapped"]},{"year":null,"claim":"Key unresolved questions include: the identity of the specific NDUFS2 cysteine residues that mediate oxygen sensing, the structural basis by which the truncated exon 3-skipped isoform exerts dominant-negative effects, and whether NDUFS2 ubiquitin-dependent turnover is a regulated axis in mitochondrial quality control beyond cancer.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of NDUFS2 in the context of mammalian complex I with defined oxygen-sensing cysteines","No in vivo therapeutic validation of idebenone or folic acid for NDUFS2-deficient patients","The E3 ligase targeting NDUFS2 for ubiquitin-proteasomal degradation has not been identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,2,5]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[3,13]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,2,3,5,6]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2,5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,11]}],"complexes":["Mitochondrial complex I (NADH:ubiquinone oxidoreductase)"],"partners":["NDUFAF7","OTUB1","PRDX5","PTBP1"],"other_free_text":[]},"mechanistic_narrative":"NDUFS2 is a core catalytic subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) that resides at the interface of the peripheral and membrane arms near the ubiquinone-binding pocket and is essential for electron transfer, proton pumping, and cellular ATP production [PMID:22036843, PMID:33744462]. Arginine-85 of NDUFS2 undergoes symmetric dimethylation by the assembly factor NDUFAF7 early during peripheral arm biogenesis, stabilizing a ~400-kDa assembly intermediate [PMID:24089531], while OTUB1-mediated removal of K48-linked polyubiquitin chains controls NDUFS2 protein stability [PMID:38653740]. Beyond its bioenergetic role, NDUFS2 cysteine residues function as redox-sensitive oxygen sensors in pulmonary artery and ductus arteriosus smooth muscle cells, coupling changes in mitochondrial H₂O₂ to intracellular Ca²⁺ signaling and vascular tone [PMID:30922174]. Biallelic loss-of-function mutations in NDUFS2 cause mitochondrial complex I deficiency presenting as Leigh-like encephalopathy or isolated optic neuropathy [PMID:11220739, PMID:28031252]."},"prefetch_data":{"uniprot":{"accession":"O75306","full_name":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial","aliases":["Complex I-49kD","CI-49kD","NADH-ubiquinone oxidoreductase 49 kDa subunit"],"length_aa":463,"mass_kda":52.5,"function":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:22036843, PubMed:28031252, PubMed:30922174). Essential for the catalytic activity of complex I (PubMed:22036843, PubMed:30922174). Essential for the assembly of complex I (By similarity). Redox-sensitive, critical component of the oxygen-sensing pathway in the pulmonary vasculature which plays a key role in acute pulmonary oxygen-sensing and hypoxic pulmonary vasoconstriction (PubMed:30922174). Plays an important role in carotid body sensing of hypoxia (By similarity). Essential for glia-like neural stem and progenitor cell proliferation, differentiation and subsequent oligodendrocyte or neuronal maturation (By similarity)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/O75306/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/NDUFS2","classification":"Common Essential","n_dependent_lines":561,"n_total_lines":1208,"dependency_fraction":0.4644039735099338},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NDUFS2","total_profiled":1310},"omim":[{"mim_id":"620569","title":"LEBER-LIKE HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE 2; LHONAR2","url":"https://www.omim.org/entry/620569"},{"mim_id":"620135","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 39; MC1DN39","url":"https://www.omim.org/entry/620135"},{"mim_id":"619382","title":"LEBER-LIKE HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE 1; LHONAR1","url":"https://www.omim.org/entry/619382"},{"mim_id":"618229","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7","url":"https://www.omim.org/entry/618229"},{"mim_id":"618228","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6","url":"https://www.omim.org/entry/618228"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"},{"location":"Calyx","reliability":"Additional"},{"location":"Connecting piece","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":435.2},{"tissue":"tongue","ntpm":591.6}],"url":"https://www.proteinatlas.org/search/NDUFS2"},"hgnc":{"alias_symbol":["CI-49"],"prev_symbol":[]},"alphafold":{"accession":"O75306","domains":[{"cath_id":"1.10.645.10","chopping":"85-463","consensus_level":"medium","plddt":93.8884,"start":85,"end":463}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75306","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75306-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75306-F1-predicted_aligned_error_v6.png","plddt_mean":89.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDUFS2","jax_strain_url":"https://www.jax.org/strain/search?query=NDUFS2"},"sequence":{"accession":"O75306","fasta_url":"https://rest.uniprot.org/uniprotkb/O75306.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75306/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75306"}},"corpus_meta":[{"pmid":"11220739","id":"PMC_11220739","title":"Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy.","date":"2001","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11220739","citation_count":153,"is_preprint":false},{"pmid":"24089531","id":"PMC_24089531","title":"NDUFAF7 methylates arginine 85 in the NDUFS2 subunit of human complex I.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24089531","citation_count":87,"is_preprint":false},{"pmid":"30922174","id":"PMC_30922174","title":"Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute Oxygen-Sensing and Hypoxic Pulmonary Vasoconstriction.","date":"2019","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/30922174","citation_count":84,"is_preprint":false},{"pmid":"20819849","id":"PMC_20819849","title":"The p.M292T NDUFS2 mutation causes complex I-deficient Leigh syndrome in multiple families.","date":"2010","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20819849","citation_count":70,"is_preprint":false},{"pmid":"30885944","id":"PMC_30885944","title":"S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30885944","citation_count":63,"is_preprint":false},{"pmid":"23266820","id":"PMC_23266820","title":"Leigh syndrome associated with mitochondrial complex I deficiency due to novel mutations In NDUFV1 and NDUFS2.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23266820","citation_count":48,"is_preprint":false},{"pmid":"28031252","id":"PMC_28031252","title":"Compound heterozygosity for severe and hypomorphic NDUFS2 mutations cause non-syndromic LHON-like optic neuropathy.","date":"2016","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28031252","citation_count":46,"is_preprint":false},{"pmid":"33744462","id":"PMC_33744462","title":"Complex I protein NDUFS2 is vital for growth, ROS generation, membrane integrity, apoptosis, and mitochondrial energetics.","date":"2021","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/33744462","citation_count":32,"is_preprint":false},{"pmid":"22036843","id":"PMC_22036843","title":"A catalytic defect in mitochondrial respiratory chain complex I due to a mutation in NDUFS2 in a patient with Leigh syndrome.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22036843","citation_count":28,"is_preprint":false},{"pmid":"35338200","id":"PMC_35338200","title":"Reduced expression of mitochondrial complex I subunit Ndufs2 does not impact healthspan in mice.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35338200","citation_count":26,"is_preprint":false},{"pmid":"38841852","id":"PMC_38841852","title":"LncRNA DCRT Protects Against Dilated Cardiomyopathy by Preventing NDUFS2 Alternative Splicing by Binding to PTBP1.","date":"2024","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/38841852","citation_count":23,"is_preprint":false},{"pmid":"38653740","id":"PMC_38653740","title":"OTUB1/NDUFS2 axis promotes pancreatic tumorigenesis through protecting against mitochondrial cell death.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38653740","citation_count":7,"is_preprint":false},{"pmid":"37034225","id":"PMC_37034225","title":"PTPMT1 regulates mitochondrial death through the SLC25A6-NDUFS2 axis in pancreatic cancer cells.","date":"2023","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37034225","citation_count":6,"is_preprint":false},{"pmid":"32279995","id":"PMC_32279995","title":"LASS2 regulates hepatocyte steatosis by interacting with NDUFS2/OXPHOS related proteins.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32279995","citation_count":5,"is_preprint":false},{"pmid":"38195952","id":"PMC_38195952","title":"NUDT21 interacts with NDUFS2 to activate the PI3K/AKT pathway and promotes pancreatic cancer pathogenesis.","date":"2024","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38195952","citation_count":4,"is_preprint":false},{"pmid":"39789601","id":"PMC_39789601","title":"An integrated investigation of mitochondrial genes in COPD reveals the causal effect of NDUFS2 by regulating pulmonary macrophages.","date":"2025","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/39789601","citation_count":2,"is_preprint":false},{"pmid":"36462614","id":"PMC_36462614","title":"Analysis of compound heterozygous and homozygous mutations found in peripheral subunits of human respiratory Complex I, NDUFS1, NDUFS2, NDUFS8 and NDUFV1, by modeling in the E. coli enzyme.","date":"2022","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/36462614","citation_count":2,"is_preprint":false},{"pmid":"39226079","id":"PMC_39226079","title":"Decreased in Mitochondrial Complex I Subunit NDUFS2 Is Critical for Oocyte Quality During Postovulatory Aging in Pigs.","date":"2024","source":"Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada","url":"https://pubmed.ncbi.nlm.nih.gov/39226079","citation_count":1,"is_preprint":false},{"pmid":"40791373","id":"PMC_40791373","title":"ndufs2-/- zebrafish have impaired survival, neuromuscular activity, morphology, and one-carbon metabolism treatable with folic acid.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40791373","citation_count":1,"is_preprint":false},{"pmid":"41924720","id":"PMC_41924720","title":"Sodium butyrate promotes the function of NDUFS2 in bovine skeletal muscle fiber type transformation and mitochondrial biosynthesis.","date":"2026","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/41924720","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.16.664929","title":"<i>ndufs2<sup>-/-</sup>  </i> zebrafish have impaired survival, neuromuscular activity, morphology, and one-carbon metabolism treatable with folic acid","date":"2025-07-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.16.664929","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.08.663799","title":"NDUFS2 (NADH:Ubiquinone oxidoreductase core subunit S2) in Mitochondrial Electron Transport Chain Complex I is Critical to Oxygen Responsiveness of Human Ductus Arteriosus Smooth Muscle Cells","date":"2025-07-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.08.663799","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13423,"output_tokens":3662,"usd":0.0476},"stage2":{"model":"claude-opus-4-6","input_tokens":7053,"output_tokens":2757,"usd":0.156285},"total_usd":0.203885,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Missense mutations in NDUFS2 that substitute conserved amino acids cause mitochondrial complex I deficiency, establishing NDUFS2 as a structural/functional subunit of complex I encoded by nuclear DNA.\",\n      \"method\": \"RT-PCR and direct DNA sequencing of patient cDNA; biochemical complex I deficiency confirmed\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple patient mutations with biochemical complex I deficiency, replicated across multiple families\",\n      \"pmids\": [\"11220739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDUFAF7 (a complex I assembly factor) symmetrically dimethylates the ω-NG,NG' atoms of Arg-85 in the NDUFS2 subunit of complex I; this methylation occurs early in assembly and stabilizes a ~400-kDa subcomplex forming the initial nucleus of the peripheral arm.\",\n      \"method\": \"Mass spectrometry identification of methylated Arg-85; biochemical methyltransferase assay; subcomplex isolation and characterization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical identification of modification site with MS and functional assembly characterization\",\n      \"pmids\": [\"24089531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The Asp446Asn mutation in NDUFS2 causes a catalytic defect in complex I without reducing complex I abundance, and 3D modeling places Asp446 near the coenzyme Q binding pocket, suggesting the mutation impairs coenzyme Q reduction or coupling to proton pumping; wild-type NDUFS2 transduction rescued the enzymatic defect in patient fibroblasts.\",\n      \"method\": \"Biochemical complex I activity assay in patient fibroblasts; coenzyme Q analog KM measurements; 3D structural modeling; lentiviral rescue with wild-type NDUFS2\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — enzymatic assay, structural modeling, and functional rescue by complementation\",\n      \"pmids\": [\"22036843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NDUFS2 is the molecular oxygen sensor at the rotenone-binding site of complex I in pulmonary artery smooth muscle cells (PASMCs); acute hypoxia reduces NDUFS2 cysteine residues and inhibits complex I, decreasing mitochondrial H2O2, which then increases intracellular Ca2+ to drive hypoxic pulmonary vasoconstriction (HPV). siRNA knockdown of NDUFS2 (but not NDUFS1, the Rieske Fe-S center, or COX4i2) abolished hypoxia-induced Ca2+ increases and attenuated HPV in vivo.\",\n      \"method\": \"siRNA knockdown in PASMCs; intracellular Ca2+ imaging; H2O2 measurement; NADH/NAD+ ratio; Kv1.5 expression; isolated lung bioassay; in vivo siNdufs2 with rotenone/phenylephrine challenge; redox state of cysteine residues measured during hypoxia\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Ca2+ imaging, H2O2 measurement, in vivo pharmacology, genetic KD with epistasis controls), replicated with different readouts\",\n      \"pmids\": [\"30922174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"S100A4 regulates NDUFS2 expression; depletion of either S100A4 or NDUFS2 inhibits mitochondrial complex I activity, reduces ATP levels, and decreases invasive/metastatic capacity of lung cancer cells, with metabolic shift to glycolysis via hexokinase upregulation.\",\n      \"method\": \"siRNA silencing of S100A4 and NDUFS2; oxygen consumption rate measurement; ATP assays; 3D invasion assays; in vivo xenograft metastasis models; hexokinase expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple phenotypic readouts in vitro and in vivo, but regulatory mechanism upstream of NDUFS2 not fully resolved\",\n      \"pmids\": [\"30885944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CRISPR/Cas9 knockout of NDUFS2 in HEK293 cells demonstrates it is required for complex I-specific respiration, ATP production, and cell membrane integrity; loss increases ROS and apoptosis/necrosis. Idebenone treatment partially restored growth, ATP, and oxygen consumption in NDUFS2 mutant cells.\",\n      \"method\": \"CRISPR/Cas9 knockout; Seahorse respirometry; ROS measurement; ATP assay; cell viability assays; idebenone pharmacological rescue\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — clean genetic KO with multiple orthogonal functional readouts plus pharmacological rescue\",\n      \"pmids\": [\"33744462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The lncRNA DCRT binds PTBP1 in the nucleus of cardiomyocytes to prevent skipping of the third exon of NDUFS2; loss of DCRT causes PTBP1-mediated exon 3 skipping of NDUFS2, producing a truncated isoform that competitively inhibits full-length NDUFS2/complex I activity and binds PRDX5 to suppress its antioxidant activity, leading to mitochondrial dysfunction and dilated cardiomyopathy.\",\n      \"method\": \"CRISPR-Cas9 DCRT knockout mice; RNA immunoprecipitation; chromatin co-IP; isoform sequencing; Western blot; co-IP of truncated NDUFS2 with PRDX5; complex I activity assay; transverse aortic constriction model; AAV overexpression rescue\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (RIP, co-IP, isoform sequencing, KO mice, in vivo rescue) establishing molecular mechanism\",\n      \"pmids\": [\"38841852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"OTUB1, a deubiquitinase, interacts with NDUFS2 and removes K48-linked polyubiquitin chains from NDUFS2, increasing its protein stability and thereby promoting pancreatic cancer cell survival, proliferation, and migration.\",\n      \"method\": \"Protein mass spectrometry; co-immunoprecipitation; OTUB1 overexpression/knockdown with NDUFS2 protein level measurement; ubiquitination assay; in vivo xenograft experiments\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP and functional epistasis, but deubiquitination mechanism needs deeper biochemical validation\",\n      \"pmids\": [\"38653740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PTPMT1 interacts with NDUFS2 (and SLC25A6) in pancreatic cancer cells, and PTPMT1 silencing impairs mitochondrial function, suggesting PTPMT1 regulates mitochondrial activity via this axis.\",\n      \"method\": \"Co-immunoprecipitation; siRNA knockdown; mitochondrial function assays; PTPMT1 inhibitor (alexidine dihydrochloride)\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP without deeper mechanistic follow-up of the NDUFS2 interaction\",\n      \"pmids\": [\"37034225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LASS2 interacts with NDUFS2 (identified by co-IP and LC-MS); this interaction is associated with mtROS production and AMPK phosphorylation, linking the LASS2-NDUFS2 axis to regulation of hepatic lipid metabolism.\",\n      \"method\": \"Co-immunoprecipitation and LC-MS; LASS2 overexpression/knockdown in hepatocytes; mtROS measurement; AMPK phosphorylation assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP/MS with limited mechanistic follow-up of the NDUFS2 interaction specifically\",\n      \"pmids\": [\"32279995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Disease-causing mutations in NDUFS2 (mapped to subunit interfaces in the E. coli homolog nuoCD) disrupt complex I assembly as demonstrated in a bacterial model system; compound heterozygous mutations were ranked for severity by NADH oxidase activity and co-immunoprecipitation-based assembly assays.\",\n      \"method\": \"Site-directed mutagenesis of E. coli nuoCD (NDUFS2 ortholog); membrane vesicle NADH oxidase activity assays; co-immunoprecipitation assembly assays; time-delayed expression experiments\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted bacterial model with mutagenesis and assembly assays, but indirect (bacterial ortholog) system\",\n      \"pmids\": [\"36462614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Compound heterozygous NDUFS2 mutations (p.Tyr53Cys; p.Tyr308Cys) cause non-syndromic LHON-like optic neuropathy; functional analysis in yeast (Y. lipolytica) showed the severe mutation abolishes complex I while the hypomorphic mutation moderately reduces NADH-ubiquinone oxidoreductase activity, establishing a genotype-phenotype correlation.\",\n      \"method\": \"Genetic mapping and whole-exome sequencing; functional analysis in patient fibroblasts (complex I abundance and respiratory chain activity); Y. lipolytica ortholog (NUCM) mutagenesis with complex I activity assay\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ortholog functional assay in yeast combined with patient fibroblast biochemistry\",\n      \"pmids\": [\"28031252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ndufs2-/- zebrafish (CRISPR/Cas9-generated) show 80% reduced complex I enzyme activity, severe neuromuscular dysfunction, metabolic disruption (elevated lactate, TCA intermediates, acyl-carnitines), and dysregulation of one-carbon metabolism; folic acid treatment rescued growth defects and hepatomegaly, implicating one-carbon metabolism in CI disease pathophysiology.\",\n      \"method\": \"CRISPR/Cas9 knockout zebrafish; complex I enzyme activity assay; transcriptome profiling; unbiased metabolomics; folic acid rescue experiment\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with enzymatic confirmation, metabolomics, and pharmacological rescue; preprint\",\n      \"pmids\": [\"40791373\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NDUFS2 acts as a mitochondrial oxygen sensor in human ductus arteriosus smooth muscle cells (DASMC): siNDUFS2 uniquely suppressed O2-induced increases in intracellular Ca2+, cell shortening, and mitochondrial ROS generation, while knockdown of other ETC subunits (NDUFS1, NDUFS7, UQCRFS1, COX4I2) had no effect, and this did not require inhibition of overall mitochondrial respiration.\",\n      \"method\": \"siRNA knockdown of NDUFS2 and comparator ETC subunits; intracellular Ca2+ imaging; cell length measurements; mitochondrial ROS measurement; micropolarimetry; complex I/III/IV activity assays; 3' RNA sequencing\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal readouts with genetic epistasis controls; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.07.08.663799\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"NDUFS2 is a core catalytic subunit of mitochondrial respiratory chain complex I located at the interface between the peripheral and membrane arms near the coenzyme Q/ubiquinone binding pocket; it harbors iron-sulfur clusters, undergoes symmetric arginine dimethylation at Arg-85 by NDUFAF7 early in complex I assembly, is subject to deubiquitination-mediated stabilization by OTUB1, and its cysteine residues act as redox-sensitive oxygen sensors that couple mitochondrial H2O2 production to intracellular Ca2+ signaling in pulmonary and ductus arteriosus smooth muscle cells, while alternative splicing of its exon 3 (regulated by lncRNA DCRT via PTBP1) produces a dominant-negative isoform that inhibits complex I activity and suppresses PRDX5 antioxidant function.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NDUFS2 is a core catalytic subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) that resides at the interface of the peripheral and membrane arms near the ubiquinone-binding pocket and is essential for electron transfer, proton pumping, and cellular ATP production [PMID:22036843, PMID:33744462]. Arginine-85 of NDUFS2 undergoes symmetric dimethylation by the assembly factor NDUFAF7 early during peripheral arm biogenesis, stabilizing a ~400-kDa assembly intermediate [PMID:24089531], while OTUB1-mediated removal of K48-linked polyubiquitin chains controls NDUFS2 protein stability [PMID:38653740]. Beyond its bioenergetic role, NDUFS2 cysteine residues function as redox-sensitive oxygen sensors in pulmonary artery and ductus arteriosus smooth muscle cells, coupling changes in mitochondrial H₂O₂ to intracellular Ca²⁺ signaling and vascular tone [PMID:30922174]. Biallelic loss-of-function mutations in NDUFS2 cause mitochondrial complex I deficiency presenting as Leigh-like encephalopathy or isolated optic neuropathy [PMID:11220739, PMID:28031252].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of patient missense mutations established NDUFS2 as a nuclear-encoded structural/functional subunit whose integrity is required for complex I enzymatic activity.\",\n      \"evidence\": \"RT-PCR, DNA sequencing, and biochemical complex I assay in patient fibroblasts from multiple families\",\n      \"pmids\": [\"11220739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Precise catalytic role of NDUFS2 within complex I was not defined\",\n        \"No structural localization of the mutated residues within the complex\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstration that the Asp446Asn mutation impairs catalysis without reducing complex I abundance, combined with structural modeling placing Asp446 near the ubiquinone-binding pocket, positioned NDUFS2 as a catalytic subunit at the electron-transfer/proton-pumping interface.\",\n      \"evidence\": \"Complex I activity and CoQ-analog KM measurements in patient fibroblasts; 3D modeling; lentiviral wild-type NDUFS2 rescue\",\n      \"pmids\": [\"22036843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct structural evidence for the ubiquinone-binding pocket architecture was lacking in the mammalian complex\",\n        \"Mechanism by which Asp446 participates in catalysis not resolved at atomic level\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that NDUFAF7 symmetrically dimethylates Arg-85 of NDUFS2 during early assembly revealed a post-translational modification step that nucleates peripheral arm biogenesis.\",\n      \"evidence\": \"Mass spectrometry identification of dimethyl-Arg-85; in vitro methyltransferase assay; subcomplex isolation\",\n      \"pmids\": [\"24089531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional consequence of blocking Arg-85 methylation on assembled complex I activity was not determined\",\n        \"Whether other complex I subunits are co-dependently modified at this stage is unknown\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Functional analysis of compound heterozygous NDUFS2 mutations in a yeast ortholog system demonstrated allele-specific severity and established a genotype–phenotype correlation with non-syndromic optic neuropathy, expanding the clinical spectrum beyond encephalopathy.\",\n      \"evidence\": \"Whole-exome sequencing; patient fibroblast biochemistry; Yarrowia lipolytica NUCM mutagenesis with complex I activity assays\",\n      \"pmids\": [\"28031252\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Yeast ortholog system may not fully recapitulate mammalian assembly or tissue-specific phenotypes\",\n        \"Why optic nerve is selectively vulnerable to these particular mutations remains unexplained\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"NDUFS2 was identified as the molecular oxygen sensor in pulmonary artery smooth muscle cells, with its cysteine residues undergoing redox changes during hypoxia that decrease mitochondrial H₂O₂ and trigger Ca²⁺-dependent vasoconstriction — a function not shared by other ETC subunits tested.\",\n      \"evidence\": \"siRNA knockdown of NDUFS2 and control subunits in PASMCs; intracellular Ca²⁺ imaging; H₂O₂ and NADH/NAD⁺ measurements; cysteine redox profiling; isolated lung bioassay; in vivo siNdufs2 challenge\",\n      \"pmids\": [\"30922174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the specific cysteine residues responsible for oxygen sensing was not determined\",\n        \"Whether this oxygen-sensing mechanism operates in vascular beds beyond pulmonary vasculature was untested\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CRISPR knockout of NDUFS2 in human cells confirmed it is indispensable for complex I-linked respiration and cell viability, and showed that the CoQ analog idebenone can partially bypass the defect.\",\n      \"evidence\": \"CRISPR/Cas9 KO in HEK293; Seahorse respirometry; ROS, ATP, and viability assays; idebenone rescue\",\n      \"pmids\": [\"33744462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Idebenone rescue was partial — the electron entry point bypassing complex I was not resolved\",\n        \"No in vivo validation of idebenone benefit for NDUFS2 deficiency\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Modeling disease-causing NDUFS2 mutations in the bacterial ortholog nuoCD showed that mutations at subunit interfaces disrupt complex I assembly, providing a structural rationale for genotype–severity correlations.\",\n      \"evidence\": \"Site-directed mutagenesis of E. coli nuoCD; membrane vesicle NADH oxidase assays; co-IP assembly assays\",\n      \"pmids\": [\"36462614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Bacterial system lacks accessory subunits and assembly factors present in mammalian complex I\",\n        \"Assembly kinetics were inferred from endpoint assays, not real-time tracking\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The lncRNA DCRT was shown to prevent PTBP1-mediated exon 3 skipping of NDUFS2 in cardiomyocytes; loss of DCRT produces a truncated dominant-negative NDUFS2 isoform that inhibits complex I and sequesters PRDX5, causing dilated cardiomyopathy.\",\n      \"evidence\": \"CRISPR DCRT-KO mice; RNA immunoprecipitation; isoform sequencing; co-IP of truncated NDUFS2 with PRDX5; complex I assays; AAV rescue\",\n      \"pmids\": [\"38841852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether exon 3-skipped NDUFS2 isoform exists at physiologically relevant levels in human heart disease is unknown\",\n        \"Stoichiometry and structural basis of truncated NDUFS2–PRDX5 interaction not resolved\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"OTUB1 was identified as a deubiquitinase that stabilizes NDUFS2 by removing K48-linked polyubiquitin chains, linking ubiquitin-dependent protein quality control to complex I abundance in cancer cells.\",\n      \"evidence\": \"Co-IP and mass spectrometry; OTUB1 overexpression/knockdown with NDUFS2 protein measurement; ubiquitination assay; xenograft models\",\n      \"pmids\": [\"38653740\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The E3 ubiquitin ligase that ubiquitinates NDUFS2 is unknown\",\n        \"Whether OTUB1-NDUFS2 regulation occurs in non-cancer physiological contexts is untested\",\n        \"Deubiquitination site(s) on NDUFS2 were not mapped\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the identity of the specific NDUFS2 cysteine residues that mediate oxygen sensing, the structural basis by which the truncated exon 3-skipped isoform exerts dominant-negative effects, and whether NDUFS2 ubiquitin-dependent turnover is a regulated axis in mitochondrial quality control beyond cancer.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of NDUFS2 in the context of mammalian complex I with defined oxygen-sensing cysteines\",\n        \"No in vivo therapeutic validation of idebenone or folic acid for NDUFS2-deficient patients\",\n        \"The E3 ligase targeting NDUFS2 for ubiquitin-proteasomal degradation has not been identified\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 2, 5]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [3, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 11]}\n    ],\n    \"complexes\": [\n      \"Mitochondrial complex I (NADH:ubiquinone oxidoreductase)\"\n    ],\n    \"partners\": [\n      \"NDUFAF7\",\n      \"OTUB1\",\n      \"PRDX5\",\n      \"PTBP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}